Physicochemical Characterization of <i>In Vitro</i> LDL Glycation and Its Inhibition by Ellagic Acid (EA): An <i>In Vivo</i> Approach to Inhibit Diabetes in Experimental Animals

<div>Agarose gel electrophoresis of plasma LDL (lane A), native LDL (lane B), and MG-LDL (lane C) while lanes D, E, and F show a banding pattern of MG-LDL with 80, 130, and 180 <i>μ</i>M EA-treated samples. The banding pattern shows significant electrophoretic mobility change from lanes E to F as compared to MG-LDL (lane C).</div>

BioMed Research International

fig7

Figure 7

Figure 7: Physicochemical Characterization of <i>In Vitro</i> LDL Glycation and Its Inhibition by Ellagic Acid (EA): An <i>In Vivo</i> Approach to Inhibit Diabetes in Experimental Animals 

Figure 7 | Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals 